Arbutus Biopharma Corp logo

Arbutus Biopharma Corp

ABUS
Healthcare|Biotechnology|USA
$4.79
-0.34 (-6.52%)
Tangible Book
$1.32
Graham Number
$4.93

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912" ], "revenue_estimate": [ 91.1, 2.7, 55.95, 173.53 ], "ebit_estimate": [ 153, -21.3, -36.48, 66.87 ], "ebitda_estimate": [ null, null, null, null ], "net_income_estimate": [ 156.1, -18.1, -29.72, 73.89 ], "per_share_eps_estimate": [ 0.3, -0.09, -0.14, 0.34 ], "eps_nri_estimate": [ 0.3, -0.09, -0.14, 0.34 ], "dividend_estimate": [ null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null ], "pretax_income_estimate": [ 156.1, -18.1, -29.72, 73.89 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null ], "roa_estimate": [ null, null, null, null ], "roe_estimate": [ null, null, null, null ], "gross_margin_estimate": [ null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null ], "pettm_estimate": [ 16.24, 0, 0, 14.09 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 0.45, 0.45, 0.4, 0.7, 0.7, 0.7, 0.7 ], "ebit_estimate": [ -5.3, -5.3, -5.3, -5.3, -5.3, -5.3, -5.3 ], "ebitda_estimate": [ null, null, null, null, null, null, null ], "net_income_estimate": [ -4.5, -4.5, -4.5, -4.5, -4.5, -4.5, -4.5 ], "per_share_eps_estimate": [ -0.03, -0.03, -0.03, -0.02, -0.02, -0.02, -0.02 ], "eps_nri_estimate": [ -0.03, -0.03, -0.03, -0.02, -0.02, -0.02, -0.02 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -4.5, -4.5, -4.5, -4.5, -4.5, -4.5, -4.5 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }